Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.070
-0.250 (-10.78%)
At close: Nov 4, 2024, 4:00 PM
2.100
+0.030 (1.45%)
After-hours: Nov 4, 2024, 5:11 PM EST
Gain Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -21.6 | -22.27 | -17.59 | -13.89 | -3.58 | -2.19 | |
| Depreciation & Amortization | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.1 | |
| Other Amortization | 0.05 | 0.05 | 0.04 | - | - | - | |
| Stock-Based Compensation | 3.14 | 3.26 | 1.53 | 0.84 | 0.08 | - | |
| Other Operating Activities | -0.67 | -0.38 | -0.21 | 1 | - | -0.09 | |
| Change in Accounts Receivable | - | - | - | 0.01 | -0 | -0.01 | |
| Change in Accounts Payable | 1.16 | -0.64 | 1.07 | -0.52 | 0.4 | 0.01 | |
| Change in Unearned Revenue | -0.47 | 1.09 | -0.21 | 0.03 | -0.13 | 0.22 | |
| Change in Income Taxes | - | - | - | - | - | -0.01 | |
| Change in Other Net Operating Assets | -0.62 | 0 | 0.66 | 0.15 | -0.02 | 0.1 | |
| Operating Cash Flow | -18.97 | -18.87 | -14.69 | -12.37 | -3.24 | -1.87 | |
| Capital Expenditures | -0.02 | -0.02 | -0.12 | -0.09 | -0.02 | -0.01 | |
| Investment in Securities | 10.11 | 10.24 | -14.66 | - | - | - | |
| Investing Cash Flow | 10.09 | 10.22 | -14.77 | -0.09 | -0.02 | -0.01 | |
| Long-Term Debt Issued | - | - | - | - | 0.74 | - | |
| Long-Term Debt Repaid | - | -0.09 | -0.08 | -0.02 | - | - | |
| Net Debt Issued (Repaid) | -0.09 | -0.09 | -0.08 | -0.02 | 0.74 | - | |
| Issuance of Common Stock | 19.96 | 12.73 | - | 42.64 | 0 | - | |
| Other Financing Activities | -0.28 | - | - | -0.85 | -0.47 | -0.02 | |
| Financing Cash Flow | 19.59 | 12.64 | -0.08 | 41.77 | 10.49 | 1.75 | |
| Foreign Exchange Rate Adjustments | -0.09 | 0.49 | -0.02 | 0.1 | -0.04 | 0.03 | |
| Net Cash Flow | 10.62 | 4.49 | -29.57 | 29.41 | 7.19 | -0.1 | |
| Free Cash Flow | -18.99 | -18.88 | -14.81 | -12.46 | -3.26 | -1.88 | |
| Free Cash Flow Margin | - | -34217.53% | -11166.38% | -9303.42% | - | - | |
| Free Cash Flow Per Share | -1.17 | -1.45 | -1.25 | -1.23 | -1.22 | -0.84 | |
| Cash Income Tax Paid | 0.13 | 0.13 | 0 | 0 | - | 0.01 | |
| Levered Free Cash Flow | -10.06 | -9.8 | -8.2 | -6.97 | -2.28 | -0.93 | |
| Unlevered Free Cash Flow | -10.06 | -9.8 | -8.2 | -6.97 | -2.28 | -0.91 | |
| Change in Net Working Capital | -0.5 | -0.78 | -1.45 | -0.91 | 0.18 | -0.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.